Stockhub

Cell Source, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 August 2022

12 August 2022

27 July 2022

  • curprev 12:5912:59, 27 July 2022‎ Chris talk contribs‎ 709 bytes +709‎ Created page with "Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantat..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Cell_Source,_Inc.’